AnaptysBio (ANAB) Ownership - Who Owns AnaptysBio?
AnaptysBio (ANAB) Ownership Overview
- 2.26% Insiders
- 12.67% Mutual Funds
- 0.76% Other Institutional Investors
- 13.98% ETFs
- 70.34% Public Companies and Individual Investors
The ownership structure of AnaptysBio (MX:ANAB) stock is a mix of institutional, retail, and individual investors. Approximately 27.40% of the company’s stock is owned by Institutional Investors, 2.26% is owned by Insiders, and 70.34% is owned by Public Companies and Individual Investors.
The ownership structure of AnaptysBio (MX:ANAB) stock is a mix of institutional, retail, and individual investors. Approximately 27.40% of the company’s stock is owned by Institutional Investors, 2.26% is owned by Insiders, and 70.34% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 31, 2026 | John Schmid | $1,158,336 | |
| Mar 26, 2026 | Daniel Faga | $1,089,123 | |
| Jan 15, 2026 | Magda Marquet | $530,458 | |
| Dec 22, 2025 | J. Anthony Ware | $193,323 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 1,844,049 | Institution | 6.17% | 65,548,566 |
| Vanguard | 1,139,892 | Institution | 3.81% | 40,518,601 |
| Ishares | 1,090,195 | Institution | 3.65% | 38,752,071 |
| Vanguard Index Funds | 885,178 | Institution | 2.96% | 31,464,537 |
| Spdr | 743,801 | Institution | 2.49% | 26,439,150 |
| Michael Rockefeller | 717,014 | Institution | 2.40% | 25,486,980 |
| Daniel Faga | 495,965 | Insider | 1.66% | 17,629,572 |
| Tiaa-cref Funds | 373,153 | Institution | 1.25% | 13,264,097 |
| Fidelity Salem Street Trust | 297,546 | Institution | 1.00% | 10,576,570 |
| Delaware Group Equity Funds Iv | 281,196 | Institution | 0.94% | 9,995,393 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 885,178 | Institution | 2.96% | 31,464,537 |
| Tiaa-cref Funds | 373,153 | Institution | 1.25% | 13,264,097 |
| Fidelity Salem Street Trust | 297,546 | Institution | 1.00% | 10,576,570 |
| Delaware Group Equity Funds Iv | 281,196 | Institution | 0.94% | 9,995,393 |
| Victory Portfolios Iii | 226,166 | Institution | 0.76% | 8,039,297 |
| Federated Hermes Equity Funds | 210,000 | Institution | 0.70% | 7,464,660 |
| Fidelity Concord Street Trust | 206,081 | Institution | 0.69% | 7,325,355 |
| Federated Hermes Mdt Series | 180,545 | Institution | 0.60% | 6,417,653 |
| Vanguard Horizon Funds | 162,550 | Institution | 0.54% | 5,778,002 |
| Vanguard Scottsdale Funds | 136,206 | Institution | 0.46% | 4,841,578 |
FAQ
Who Owns AnaptysBio (MX:ANAB)?
According to the latest TipRanks data, approximately 27.40% of the company's stock is held by institutional investors, 2.26% is held by insiders, and 70.34% is held by public companies and individual investors.
What percentage of AnaptysBio (MX:ANAB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.40% of AnaptysBio (MX:ANAB) stock is held by institutional investors: 12.67% by mutual funds, 13.98% by ETFs and 0.76% by other institutional investors.
What percentage of AnaptysBio (MX:ANAB) stock is held by retail investors?
According to the latest TipRanks data, approximately 70.34% of AnaptysBio (MX:ANAB) stock is held by public companies and individual investors.
Who owns the most shares of AnaptysBio (MX:ANAB)?
BlackRock, Inc. owns the most shares of AnaptysBio (MX:ANAB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
